Considering an infectious etiology of sarcoidosis

Clinics in Dermatology

Volumn 25, Issue 3, 2007, Pages 259-266

  Ezzie, Michael E ^a   Crouser, Elliott D ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MINOCYCLINE;

ANTIBODY RESPONSE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; DISEASE ASSOCIATION; DISEASE TRANSMISSION; GRANULOMATOUS INFLAMMATION; HEPATITIS C; HEREDITY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RICKETTSIA; RICKETTSIA HELVETICA; RISK FACTOR; SARCOIDOSIS;

BACTERIA; BACTERIAL INFECTIONS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFECTION; INFLAMMATION; PHENOTYPE; SARCOIDOSIS;

EID: 34249819964     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.03.003     Document Type: Article

References (89)

1. Newman L.S., Rose C.S., and Maier L.A. Sarcoidosis. N Engl J Med 336 (1997) 1224-1234
2. Cummings M.M., and Hudgins P.C. Chemical constituents of pine pollen and their possible relationship to sarcoidosis. Am J Med Sci 236 (1958) 311-317
3. Vincent M., Chemarin C., Peyrol S., Thivolet F., and Champagnon B. Use of talc and sarcoidosis-pathogenic role of cutaneous talc exposure in sarcoidosis. Rev Mal Respir 21 (2004) 811-814
4. Tukiainen P., Nickels J., Taskinen E., and Nyberg M. Pulmonary granulomatous reaction: talc pneumoconiosis or chronic sarcoidosis?. Br J Ind Med 41 (1984) 84-87
5. Kim Y.C., Triffet M.K., and Gibson L.E. Foreign bodies in sarcoidosis. Am J Dermatopathol 22 (2000) 408-412
6. Kreider M.E., Christie J.D., Thompson B., et al., and for the ACCESS Research Group. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128 (2005) 207-215
7. Centers for Disease Control and Prevention (CDC), Sarcoidosis among U.S. Navy enlisted men, 1965-1993. MMWR Morb Mortal Wkly Rep 46 (1997) 539-543
8. Kajdasz D.K., Lackland D.T., Mohr L.C., and Judson M.A. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 11 (2001) 111-117
9. Kern D.G., Neill M.A., Wrenn D.S., and Varone J.C. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 148 (1993) 974-980
10. Bernard J., Rose C., Newman L., et al., ACCESS Research Group. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47 (2005) 226-234
11. Kveim A. En ny og spesifik kutan-reakjon ved Boeck's sarcoid (Preliminary report on new and specific cutaneous reaction in Boeck's sarcoid). Nord Med 9 (1941) 1969-1972
12. Siltzbach L. The Kveim test in sarcoidosis. JAMA 178 (1961) 476-482
13. Holter J.H., Park H., Sjoerdsma K., and Kataria Y. Nonviable autologous bronchoalveolar lavage preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients. Am Rev Respir Dis 145 (1992) 864-871
14. Richter E., Kataria Y.P., Zissel G., Homolka J., Schlaak M., and Muller-Quernheim J. Analysis of the Kveim-Siltzbach test reagent for bacterial DNA. Am J Respir Crit Care Med 159 (1999) 1981-1982
15. Parkes S.A., Baker S.B., Bourdillon R.E., Murray C.R., and Rakshit M. Epidemiology of sarcoidosis in the Isle of Man-1: a case controlled study. Thorax 42 (1987) 420-426
16. Smith P.G., and Pike M.C. Generalizations of two tests for the detection of household aggregation of disease. Biometrics 32 (1976) 817-828
17. Hills S.E., Parkes S.A., and Baker S.B. Epidemiology of sarcoidosis in the Isle of Man-2: evidence for space-time clustering. Thorax 42 (1987) 427-430
18. Heyll A., Meckenstock G., Aul C., et al. Possible transmission of sarcoidosis via allogenic bone marrow transplantation. Bone Marrow Transplant 14 (1994) 161-164
19. Burke W.M.J., Keogh A., Maloney P.J., Delprado W., Bryant D.H., and Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 336 (1990) 1579
20. Muller C., Briegel J., Haller M., et al., the Munich Lung Transplant Group. Sarcoidosis recurrence following lung transplantation. Transplantation 61 (1996) 1117-1119
21. Glennas A., Kvein T.K., Melby K., et al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 34 (1995) 45-50
22. Panayeas S., Theodorakopoulos P., Bouras A., and Constantopoulos S. Seasonal occurrence of sarcoidosis in Greece. Lancet 338 (1991) 510-511
23. Wilsher M.L. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J 12 (1998) 1197-1199
24. Fite E., Alsina J.M., Mana J., Pujol R., Ruiz J., and Morera J. Epidemiology of sarcoidosis in Catalonia: 1979-1989. Sarcoidosis Vasc Diffuse Dis 13 (1996) 153-158
25. Pauluzzi P., Gonzalez-Inchaurraga M.A., Bonin S., and Trevisant G. Pulmonary tuberculosis with cutaneous aspects of sarcoidosis. J Eur Acad Derm Venereol 16 (2002) 411-412
26. Ball N.J., Kho G.T., and Matinka M. The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol 31 (2004) 160-168
27. Thomas M.M., Jacob M., Chandi S.M., et al. Role of S-100 staining in differentiating leprosy from other granulomatous diseases of the skin. Int J Lepr Other Mycobact Dis 67 (1999) 1-5
28. Gazouli M., Ikonomopoulos J., Trigidou R., Foteinou M., Kittas C., and Gorgoulis V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 40 (2002) 3060-3063
29. Fite E., Fernandez-Figueras M.T., Prats R., Vaquero M., and Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 73 (2006) 20-26
30. Drake W.P., Pei Z., Pride D.T., Collins R.D., Cover T.L., and Blaser M.J. Molecular analysis of sarcoidosis tissues for Mycobacterium species DNA. Emerg Infect Dis 8 (2002) 1334-1341
31. Richter E., Greinert U., Kirsten D., et al. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 153 (1996) 375-380
32. Song Z., Marzilli L., Greenlee B.M., et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201 (2005) 755-767
33. Bergeron A., Laissy J.P., Loiseau P., Schouman-Claeys E., Hance A.J., and Tazi A. Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats. Eur Respir J 18 (2001) 357-361
34. Hosoda Y., Sasagawa S., and Yamaguchi T. Sarcoidosis and tuberculosis: epidemiological similarities and dissimilarities. A review of a series of studies in a Japanese work population (1941-1996) and the general population (1959-1984). Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 85-93
35. Yasahara T., Tada R., Nakano Y., et al. The presence of Propionibacterium spp. In the vitreous fluid of uveitis patients with sarcoidosis. Acta Ophthalmol Scand 83 (2005) 364-369
36. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40 (2002) 198-204
37. Ebe Y., Ikushima S., Yamaguchi T., et al. Proliferative response of peripheral blood cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17 (2000) 256-265
38. Ichiyasu H., Suga M., Matsukawa A., et al. Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 65 (1999) 482-491
39. Nishiwaka T., Yoneyama H., Eishi Y., et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 165 (2004) 631-639
40. Bachelez H., Senet P., Cadranel J., Kaouhkov A., and Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137 (2001) 69-73
41. Hua B., Li Q.D., Wang F.M., Ai C.X., and Luo W.C. Borrelia burgdorferi infection may be the cause of sarcoidosis. Chin Med J (Engl) 105 (1992) 560-563
42. Lian W., and Luo W. Borrelia burgdorferi DNA in biological samples from patients with sarcoidosis using the polymerase chain reaction technique. Chin Med Sci J 10 (1995) 93-95
43. Ishihara M., Ohno S., Ono H., et al. Seroprevalence of anti-Borrelia antibodies among patients with confirmed sarcoidosis in a region of Japan where Lyme borreliosis is endemic. Graefes Arch Clin Exp Ophthalmol 236 (1998) 280-284
44. Morris J.T., and Longfield R.N. Sarcoidosis and ELISA for Borrelia burgdorferi. South Med J 87 (1994) 590-591
45. Arcangeli G., Calabro S., Cisno F., Zambotto F.M., Drigo R., and Ferraresso A. Determination of antibodies to Borrelia burgdorferi in sarcoidosis. Sarcoidosis 11 (1994) 32-33
46. Martens H., Zollner B., Zissel G., Burdon D., Schlaak M., and Muller-Quernheim J. Anti-Borrelia burgdorferi immunoglobulin seroprevalence in pulmonary sarcoidosis: a negative report. Eur Respir J 10 (1997) 1356-1358
47. Nilsson K., Pahlson C., Lukinius A., Eriksson L., Nilsson L., and Lindquist O. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis 185 (2002) 1128-1138
48. Planck A., Eklund A., Grunewald J., and Vene S. No serologic evidence of Rickettsia helvetica infection in Scandinavian sarcoidosis patients. Eur Respir J 24 (2004) 811-813
49. Silva V.M., Kanaujia G., Gennaro M.L., and Menzies D. Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis. Int J Tuberc Lung Dis 7 (2003) 478-484
50. Sapadin A.N., and Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54 (2006) 258-265
51. Schaumann J. On the nature of certain peculiar corpuscles present in tissue of lymphogranulomatosis benigna. Acta Med Scand 106 (1941) 648-652
52. Ang S.C., and Moscovic E.A. Cross-reactive and species specific Mycobacterium tuberculosis antigens in the immunoprofile of Schaumann bodies: a major clue to the etiology of sarcoidosis. Histol Histopathol 11 (1996) 125-134
53. Alavi H.A., and Moscovic E.A. Immunolocalization of cell-wall-deficient forms of Mycobacterium tuberculosis complex in sarcoidosis and in sinus histiocytosis of lymph nodes draining carcinoma. Histol Histopathol 11 (1996) 683-694
54. Johnson L.A., Edsell J.R., Austin J.H., and Ellis K. Pulmonary sarcoidosis: could mycoplasma-like organisms be a cause?. Sarcoidosis Vasc Diffuse Lung Dis 13 (1996) 38-42
55. Almenoff P.L., Johnson A., Lesser M., and Mattman L.H. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 51 (1996) 530-533
56. Brown S.T., Brett I., Almenoff P.L., Lesser M., Terrin M., Teirstein A.S., and ACCESS Research Group. Recovery of cell wall-deficient organisms from blood does not distinguish patients with sarcoidosis and control subjects. Chest 123 (2003) 413-417
57. el-Zaatari F.A., Naser S.A., Markesich D.C., Kalter D.C., Engstand L., and Graham D.Y. Identification of Mycobacterium avium complex in sarcoidosis. J Clin Microbiol 34 (1996) 2240-2245
58. Di Alberti L., Piattelli A., Artese L., et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 350 (1997) 1655-1661
59. Bassoe C.F., Hausken T., Bostad L., and Kristofferson E.K. Co-occurrence of Epstein-Barr virus and ascites in sarcoidosis. Scand J Infect Dis 36 (2004) 232-234
60. McKee D.H., Young A.C., and Haeney M. Sarcoidosis and HTLV-1 infection. J Clin Pathol 58 (2005) 996-997
61. Knoell K.A., Hendrix Jr. J.D., Stoler M.H., Patterson J.W., and Montes C.M. Absence of human herpesvirus 8 in sarcoidosis and Crohn disease granulomas. Arch Dermatol 141 (2005) 909-910
62. Maeda H., Niimi T., Sato S., et al. Human herpesvirus 8 is not associated with sarcoidosis in Japanese patients. Chest 118 (2000) 923-927
63. Bolukbas C., Bolukbas F.F., Kebdir T., et al. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C-a case report and review of the literature. Acta Gastreonterol Belg 68 (2005) 432-434
64. Celik G., Sen E., Ulger A.F., et al. Sarcoidosis caused by interferon therapy. Respirology 10 (2005) 535-540
65. Ramos-Casals M., Mana J., Nardi N., et al., HISPAMEC Study Group. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 84 (2005) 69-80
66. Tsimpoukas F., Goritsas C., Papadopoulos N., Trigidou R., and Ferti A. Sarcoidosis in untreated chronic hepatitis C virus infection. Scand J Gastroenterol 39 (2004) 401-403
67. Foulon G., Wislez M., Naccache J.M., et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38 (2004) 418-425
68. Newman L.S., Rose C.S., Bresnitz E.A., et al., ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
69. Valeyre D., Soler P., Clerici C., et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations,alveolitis, and the evolution of disease. Thorax 43 (1988) 516-524
70. Laan M., Bozinovski S., and Anderson G.P. Production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol 173 (2004) 4164-4170
71. Drannik A.G., Pouladi M.A., Robbins C.S., Goncharova S.I., Kianpour S., and Stampfli M.R. Impact of cigarette smoking on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 170 (2004) 1164-1171
72. de Jonge W.J., van der Zanden E.P., The F.O., et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6 (2005) 844-851
73. Cozen W., Diaz-Sanchez D., Gauderman W.J., et al. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol 24 (2004) 617-622
74. Tromp G., Kuivaniemi H., Raphael S., et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 59 (1996) 1097-1107
75. Miceli-Richard C., Lesage S., Rybojad M., et al. CARD15 mutations in Blau syndrome. Nat Gen 29 (2001) 19-20
76. Kobayashi K.S., Chamaillard M., Ogura Y., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
77. Rybicki B.A., Maliarik M.J., Bock C.H., et al. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 203-208
78. Kanazawa N., Okafuji I., Kambe N., et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kB activation: common genetic etiology with Blau syndrome. Blood 105 (2005) 1195-1197
79. Martinon F., and Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004) 561-574
80. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
81. Li J., Moran T., Swanson E., et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 13 (2004) 1715-1725
82. Aldhous M.C., Nimmo E.R., and Satsangi J. NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease. Gut 52 (2003) 1533-1535
83. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
84. Conron M., Bondeson J., Pantelidis P., et al. Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenoviral infection and allow analysis of NF-kappa b-dependent signaling pathways. Antioxid Redox Signal 25 (2001) 141-149
85. Rossman M.D., Thompson B., Fredrick M., et al., ACCESS Group. HLA_DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73 (2003) 720-735
86. Schürmann M., Reichel P., Müller-Myhsok B., Schlaak M., Müller-Quernheim J., and Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 164 (2001) 840-846
87. Valentonyte R., Hampe J., Huse K., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37 (2005) 357-364
88. Grosser M., Luther T., Fuessel M., Bickardt J., Magdolen V., and Baretton G. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 66-74
89. Baughman R.P., Lower E.E., and du Bois R.M. Sarcoidosis. Lancet 361 (2003) 1111-1118